Risk for subsequent development of brain cancer increased in cohort of mostly male veterans.
News
Bevacizumab may improve the efficacy of chemotherapy but increase toxicity when given to pediatric patients with relapsed or refractory, high-risk neuroblastoma.
More responses, longer progression-free survival seen compared with standard chemo for low-grade glioma with BRAF V600 mutations.
Significant improvement seen in progression-free survival and in time to next intervention for vorasidenib versus placebo.
A pilot study investigated the association between distress levels and communication needs in patients with glioma.
If approved, vorasidenib could become a new standard of care for low-grade IDH1/2-mutated gliomas, according to an ASCO discussant.
An ultrasound technique allows for delivery of albumin-bound paclitaxel across the blood-brain barrier in patients with recurrent glioblastoma, a study suggests.
GD2-targeted CAR T cells expanded in vivo, and were detectable in peripheral blood up to 30 months after infusion.
Risk for cancer transmission lower than thought, and long-term transplant outcomes favorable.
Adding interferon alfa to treatment with temozolomide and radiotherapy prolongs survival in patients with newly diagnosed, high grade glioma, a phase 3 trial suggests.